Chemical structures of ABT-737 (left) and ABT-263 (right ). | Download Scientific Diagram
ABT-737 - Wikipedia
ABT-737 -
ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells | Cell Death & Disease
PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors
Frontiers | Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent
ABT-737 is a Selective and BH3 Mimetic Bcl-2, Bcl-xL and Bcl-w Inhibitor - Network of Cancer Research
Chemical structure and mode of action of the BH3 mimetic ABT-737 in... | Download Scientific Diagram
ABT-737 affected cell growth, induced apoptosis and modulated Bcl-2... | Download Scientific Diagram
ABT-737 - LKT Labs
Combined treatment with ABT-737 and VX-680 induces apoptosis in Bcl-2- and c-FLIP-overexpressing breast carcinoma cells
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins | Oncogene
Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B – topic of research paper in Biological sciences. Download scholarly article
Combined treatment with ABT-737 and VX-680 induces apoptosis in Bcl-2- and c-FLIP-overexpressing breast carcinoma cells
![ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2013/144/1/fig-8-2x.jpg "ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]")
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]
Ionizing Radiation Sensitizes Breast Cancer Cells to Bcl-2 Inhibitor, ABT- 737, through Regulating Mcl-1
ABT-737|Bcl-2 inhibitor|CAS# 852808-04-9 - APExBIO
ABT-737 | Bcl-2 Family Inhibitor/BH3 Mimetic | MedChemExpress
![ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2013/144/1/fig-1-full.png "ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]")
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]
Frontiers | BH3 Mimetics for the Treatment of Prostate Cancer
Cancers | Free Full-Text | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death
ABT-737 and Roscovitine induces apoptosis in a synergistic fashion in mast cells carrying the D816V KIT mutation
Navitoclax - Wikipedia
IJMS | Free Full-Text | BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin–DNA adducts - ScienceDirect
